Stock Events

Stock Events

Alzinova 

SEK1.7500
2
+SEK0.00+0% Monday 14:35

Statistics

Day High
1.756
Day Low
1.75
52W High
2.1
52W Low
1.702
Volume
49,000
Avg. Volume
303,969
Mkt Cap
354.62M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-26.27MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap32.63B
Biogen focuses on neurodegenerative diseases, similar to Alzinova's focus on Alzheimer's disease.
Lilly(Eli) &
LLY
Mkt Cap1.02T
Eli Lilly is developing treatments for Alzheimer's, directly competing in Alzinova's primary market.
Pfizer
PFE
Mkt Cap162.16B
Pfizer has a history of developing Alzheimer's treatments, positioning it as a competitor in the same therapeutic area.
Merck
MRK
Mkt Cap370.89B
Merck is engaged in developing therapies for Alzheimer's disease, making it a direct competitor.
Abbott Laboratories
ABT
Mkt Cap187.45B
Abbott Laboratories, through its neurological research, competes in the Alzheimer's treatment market.
Novartis
NVS
Mkt Cap304.1B
Novartis focuses on CNS diseases including Alzheimer's, competing with Alzinova in research and drug development.
Johnson & Johnson
JNJ
Mkt Cap663.28B
Johnson & Johnson conducts extensive research in neurodegenerative diseases, including Alzheimer's.
AC Immune SA
ACIU
Mkt Cap284.36M
AC Immune specifically targets Alzheimer's and neurodegenerative diseases, closely competing with Alzinova.

About

Alzinova AB (publ) is a Swedish biotechnology company dedicated to advancing novel immunotherapies against Alzheimer's disease. Their primary investigational product, ALZ-101, is a vaccine specifically designed to target oligomers responsible for Alzheimer's. Additionally, they are developing ALZ-201, a monoclonal antibody aimed at neutralizing harmful amyloid-beta (Aß) oligomers. Established in 2011, the company's operations are headquartered in Mölndal, Sweden.
Show more...
CEO
Tord Labuda
Employees
7
Country
Sweden
ISIN
SE0024668214

Listings

ST
SE
ALZ-BTA.ST
STU
DE
78D.STU
F
DE
78D.F
ST
SE
ALZ.ST

0 Comments

Share your thoughts

FAQ

What is Alzinova stock price today?▼
The current price of ALZ-BTA.ST is SEK1.75 SEK — it has increased by +0% in the past 24 hours. Watch Alzinova stock price performance more closely on the chart.
What is Alzinova stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Stockholm Exchange exchange Alzinova stocks are traded under the ticker ALZ-BTA.ST.
What is Alzinova market cap?▼
Today Alzinova has the market capitalization of 354.62M
When is the next Alzinova earnings date?▼
Alzinova is going to release the next earnings report on November 12, 2026.
What is Alzinova revenue for the last year?▼
Alzinova revenue for the last year amounts to 0 SEK.
What is Alzinova net income for the last year?▼
ALZ-BTA.ST net income for the last year is -26.27M SEK.
How many employees does Alzinova have?▼
As of September 12, 2026, the company has 7 employees.
In which sector is Alzinova located?▼
Alzinova operates in the Health & Wellness sector.
When did Alzinova complete a stock split?▼
Alzinova has not had any recent stock splits.
Where is Alzinova headquartered?▼
Alzinova is headquartered in Mölndal, Sweden.